Post op pain management

Reading File

Asking for Preferences

LCP

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have excellent content from multiple authoritative textbooks. Here is a comprehensive answer on LCP (Local Continuous Perfusion) in the context of postoperative pain management.

Post-Operative Pain Management: LCP (Local Continuous Perfusion / Local Infiltration Analgesia)

What is LCP?

Local Continuous Perfusion (LCP) refers to the placement of a wound soaker catheter (e.g., the On-Q PainBuster system) into the surgical site, through which local anesthetics are continuously infused postoperatively. It is an evolution of simple wound infiltration into a sustained delivery system. The broader term in orthopedic literature is Local Infiltration Analgesia (LIA).

LIA was originally developed for analgesia after major knee and hip surgery and involves infiltration of a local anesthetic mixture into all tissue planes of the surgical field, with an option to place a wound catheter for repeat/continuous dosing.

LIA / LCP Standard Technique

The original LIA mixture (per Miller's Anesthesia) consists of:

Component	Dose
Ropivacaine	300 mg
Ketorolac	30 mg
Epinephrine	1.5 mg
Saline	Diluted to 150-200 mL

Injected into all tissue planes over approximately 1 hour
A catheter is placed into the wound for later repeat dosing
Primarily used for TKA (total knee arthroplasty) and hip surgery

Clinical outcomes from the original series of 325 patients (mainly hip resurfacing):

Pain score 0-3 (NRS) without morphine in two-thirds of patients
Most could walk with assistance 5-6 hours after surgery
71% discharged walking independently after a single-night stay

In a blinded RCT of uncomplicated arthroplasty, LIA:

Significantly reduced pain and opioid consumption
Decreased median length of stay by 2 days
68% of patients discharged after a 1-night stay
Miller's Anesthesia, 10e, p. 10001

Evidence Summary for LIA

Surgery	Evidence
TKA (Knee)	Systematic reviews confirm effectiveness for acute pain in first 24 hours post-op
THA (Hip)	Adds little additional analgesia when a full multimodal regimen is already used

Miller's Anesthesia, 10e, p. 10001

LCP with Wound Soaker Catheters

A key limitation of single-injection infiltration is short duration of pain relief.

Continuous wound catheters extend analgesia and are associated with:

Reduced pain scores
Fewer opioid-related side effects
Shorter hospital stay
Improved patient satisfaction

For thoracic surgery, the surgeon can place a soaker catheter (e.g., On-Q PainBuster) under direct vision while the chest is open, through which local anesthetics are infused postoperatively. This is an effective adjunct after thoracic surgery as well.

Barash Clinical Anesthesia, 9e, p. 3264
Miller's Anesthesia, 10e, p. 10001

LCP in Multimodal Analgesia

LCP/LIA does not stand alone. Best practice places it within a multimodal, opioid-sparing framework:

Core Multimodal Components

Agent	Role	Key Notes
Acetaminophen	Opioid-sparing adjuvant	1,000 mg IV q6h (adults >50 kg); mechanism includes COX inhibition, serotonergic modulation, NMDA/endocannabinoid interaction
NSAIDs (e.g., ibuprofen, ketorolac)	Opioid-sparing, reduce PONV	COX-1/2 inhibition; significant reduction in opioid-related side effects
COX-2 inhibitors (celecoxib)	Equivalent to NSAIDs	400 mg orally 2 hours pre-op reduces post-op pain and opioid requirement
Gabapentinoids (gabapentin/pregabalin)	Central sensitization prevention	Bind α-2δ subunit of voltage-gated Ca²⁺ channels in dorsal horn; recommended for opioid-tolerant patients
Dexamethasone	Adjuvant	0.11-0.2 mg/kg IV pre-op; reduces neurotransmitter release, decreases kynurenic acid production
Regional/neuraxial blocks	Site-specific profound analgesia	Epidurals, perineural catheters, peripheral nerve blocks
LCP / LIA	Wound-level analgesia	As above
PCA (IV opioid)	Rescue/titrated analgesia	Efficacious vs. nurse-administered PRN; epidural PCA provides modest additional benefit at rest

NSAID + acetaminophen combination produces superior analgesia vs. either drug alone (21-trial systematic review).

Barash Clinical Anesthesia, 9e, p. 4716

Novel Extended-Duration LAs in LCP

Liposomal bupivacaine (Exparel): FDA-approved; encapsulated in biodegradable liposomes for up to 96 hours of potential analgesia. However, systematic reviews and meta-analyses show no superiority over plain bupivacaine for wound infiltration or peripheral nerve blocks. The acidity of surgical wounds is theorized to accelerate drug release.
Perineural dexamethasone: Though not FDA-approved for perineural use, IV and perineural dexamethasone show promising results in prolonging analgesia and reducing rebound pain (which affects up to 50% of patients after ambulatory orthopedic surgery).
Miller's Anesthesia, 10e, p. 10002

PCA (Patient-Controlled Analgesia) - Adjunct to LCP

When LCP alone is insufficient:

IV-PCA: patient self-administers boluses (morphine, fentanyl, hydromorphone, tramadol) with lockout intervals - moderate-quality evidence for superiority over nurse-administered PRN opioids
PCEA (Patient-Controlled Epidural Analgesia): delivers individualized epidural dosing - modest added benefit at rest vs. IV-PCA
TCI-PCA (Target-Controlled Infusion PCA): emerging technology with remifentanil/alfentanil that provides better pharmacokinetic matching to pain stimulus
Miller's Anesthesia, 10e, p. 3146

ERAS Context

Within Enhanced Recovery After Surgery (ERAS) protocols, the central tenet is multimodal opioid-sparing analgesia. LCP fits here as one of several parallel interventions:

Preoperative carbohydrate loading
Minimizing systemic opioids
Early mobilization (within 30 minutes of PACU arrival)
Regional + wound infiltration techniques

Multimodal regimens are based on two or more analgesic classes with different mechanisms of action. Synergy among analgesics allows more opioid-sparing use, reducing dependence risk and supporting the early recovery pathway.

Sabiston Textbook of Surgery, 8e, p. 379

Clinical Summary

LCP is most effective for TKA, moderately useful for THA within a multimodal plan, and serves as a useful adjunct in thoracic and abdominal surgery via wound catheters. It should always be embedded in a multimodal framework combining NSAIDs, acetaminophen, regional blocks, and judicious opioid use (PCA if needed), targeting early mobilization and PACU discharge criteria.

This is a shared conversation. Sign in to Orris to start your own chat.